National Research (NASDAQ:NRC) Stock Price Crosses Above 200 Day Moving Average - What's Next?

Shares of National Research Corporation (NASDAQ:NRC - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $16.61 and traded as high as $19.31. National Research shares last traded at $18.74, with a volume of 132,991 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of National Research from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, March 6th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of "Sell".

National Research Stock Performance

The firm has a market cap of $426.34 million, a P/E ratio of 48.05 and a beta of 0.31. The company has a debt-to-equity ratio of 5.36, a quick ratio of 0.55 and a current ratio of 0.55. The company's 50 day moving average is $16.39 and its 200 day moving average is $16.61.

National Research (NASDAQ:NRC - Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The business had revenue of $34.80 million during the quarter. National Research had a net margin of 6.52% and a return on equity of 117.08%.

National Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 10th. Investors of record on Friday, June 26th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.4%. National Research's dividend payout ratio (DPR) is currently 164.10%.

Institutional Investors Weigh In On National Research

Hedge funds have recently added to or reduced their stakes in the business. CANADA LIFE ASSURANCE Co acquired a new stake in National Research during the 4th quarter worth approximately $60,000. Quadrant Capital Group LLC boosted its position in National Research by 315.9% during the 4th quarter. Quadrant Capital Group LLC now owns 2,583 shares of the company's stock worth $48,000 after buying an additional 1,962 shares during the period. Raymond James Financial Inc. acquired a new stake in National Research during the 2nd quarter worth approximately $34,000. Strs Ohio acquired a new stake in National Research during the 1st quarter worth approximately $33,000. Finally, BNP Paribas Financial Markets boosted its position in National Research by 85.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company's stock worth $32,000 after buying an additional 1,150 shares during the period. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Company Profile

National Research Corp NASDAQ: NRC, also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company's cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.